Search for a trial

A randomized Phase II study of second line treatment with liposomal irinotecan and S1 versus liposomal irinotecan and 5-fluorouracil in patients with metastatic pancreatic cancer who failed on first line gemcitabine-based chemotherapy

This study has been transitioned to CTIS with ID 2023-509463-24-01 check the CTIS register for the current data. The main objective of this study is to determine the optimal second line treatment strategy in Caucasian patients with metastatic…